Ameren Co. (NYSE:AEE - Get Free Report) was the target of unusually large options trading activity on Wednesday. Investors purchased 2,984 call options on the company. This represents an increase of approximately 2,268% compared to the average daily volume of 126 call options.
Analyst Upgrades and Downgrades
AEE has been the topic of a number of research reports. Barclays reduced their target price on shares of Ameren from $102.00 to $101.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 8th. Morgan Stanley reiterated an "outperform" rating on shares of Ameren in a research report on Wednesday, April 23rd. BMO Capital Markets boosted their target price on Ameren from $105.00 to $106.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Evercore ISI raised Ameren from an "in-line" rating to an "outperform" rating and upped their price target for the company from $89.00 to $104.00 in a research note on Tuesday, January 21st. Finally, UBS Group lifted their price objective on Ameren from $106.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, March 21st. Four analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $99.33.
Check Out Our Latest Stock Report on AEE
Insider Buying and Selling
In other news, insider Shawn E. Schukar sold 4,743 shares of the firm's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $103.79, for a total value of $492,275.97. Following the completion of the sale, the insider now directly owns 57,486 shares in the company, valued at approximately $5,966,471.94. This trade represents a 7.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Craig S. Ivey sold 2,716 shares of the company's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $98.27, for a total transaction of $266,901.32. Following the transaction, the director now owns 14,495 shares in the company, valued at approximately $1,424,423.65. This trade represents a 15.78 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 12,959 shares of company stock worth $1,316,712 in the last quarter. 0.34% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Ameren
Several institutional investors have recently modified their holdings of AEE. Synergy Investment Management LLC bought a new position in Ameren in the fourth quarter valued at approximately $25,000. Roxbury Financial LLC acquired a new stake in shares of Ameren during the fourth quarter worth $27,000. Quarry LP bought a new stake in Ameren in the 4th quarter valued at $31,000. ORG Partners LLC boosted its stake in Ameren by 74.5% in the 1st quarter. ORG Partners LLC now owns 349 shares of the utilities provider's stock worth $35,000 after purchasing an additional 149 shares during the period. Finally, Lee Danner & Bass Inc. bought a new position in Ameren during the 4th quarter worth about $38,000. Institutional investors own 79.09% of the company's stock.
Ameren Trading Up 1.5 %
Shares of Ameren stock traded up $1.45 during trading on Friday, hitting $99.54. 2,663,914 shares of the company were exchanged, compared to its average volume of 1,593,368. The company has a debt-to-equity ratio of 1.41, a current ratio of 0.66 and a quick ratio of 0.44. The firm has a market capitalization of $26.87 billion, a P/E ratio of 22.52, a price-to-earnings-growth ratio of 2.97 and a beta of 0.45. The firm's fifty day moving average price is $98.64 and its 200 day moving average price is $94.18. Ameren has a 1-year low of $69.39 and a 1-year high of $104.10.
Ameren (NYSE:AEE - Get Free Report) last issued its earnings results on Thursday, May 1st. The utilities provider reported $1.07 EPS for the quarter, missing the consensus estimate of $1.08 by ($0.01). The firm had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $1.92 billion. Ameren had a net margin of 15.51% and a return on equity of 10.34%. The firm's revenue for the quarter was up 15.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.98 EPS. As a group, sell-side analysts expect that Ameren will post 4.93 earnings per share for the current fiscal year.
Ameren Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Tuesday, March 11th were issued a $0.71 dividend. This is an increase from Ameren's previous quarterly dividend of $0.67. This represents a $2.84 annualized dividend and a dividend yield of 2.85%. The ex-dividend date was Tuesday, March 11th. Ameren's dividend payout ratio is 64.25%.
About Ameren
(
Get Free Report)
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.
Featured Stories
Before you consider Ameren, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.
While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.